Survival probability and factors associated with time to loss to follow-up and mortality among patients on antiretroviral treatment in central Kenya
Abstract Background Retention of patients who are receiving antiretroviral therapy (ART) remains a challenge especially in the setting of rapid expansion of HIV services. Retention in care remains vital to the HIV care continuum, and has been associated with viral suppression and improved survival....
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2022-06-01
|
| Series: | BMC Infectious Diseases |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12879-022-07505-0 |
| _version_ | 1828215499140366336 |
|---|---|
| author | P. Wekesa A. McLigeyo K. Owuor J. Mwangi E. Ngugi |
| author_facet | P. Wekesa A. McLigeyo K. Owuor J. Mwangi E. Ngugi |
| author_sort | P. Wekesa |
| collection | DOAJ |
| description | Abstract Background Retention of patients who are receiving antiretroviral therapy (ART) remains a challenge especially in the setting of rapid expansion of HIV services. Retention in care remains vital to the HIV care continuum, and has been associated with viral suppression and improved survival. This study aimed to ascertain survival rates, time to loss to follow-up (LTFU) or mortality events and factors associated with time to LTFU or mortality among patients enrolled on antiretroviral therapy at health facilities in central Kenya. Methods This was a retrospective cohort study among patients initiated on ART between 2004 and 2012 in central Kenya. Demographic characteristics, clinical characteristics and outcomes data were analyzed using Stata version 15.1. Competing risks regression analysis and cummulative incidence functions were used to estimate survival. Results A total of 31,346 patients were included, of whom 65.6% were female, 76.0% were aged between 20 and 50 years old, and 38.9% were diagnosed at WHO stage III. At 36 months, overall retention was 68.8%, LTFU was 27.1%, and mortality was 4.1%. The total person-years of follow up was 74,986. The incidence rate of LTFU was 9.99 per 100 person years for a total of 9383.25 person-years of follow up. The mortality rate was 1.25 per 100 person years for a total of 875.5 person-years among those who died. The median time to LTFU was 11 months (IQR 3–22) while median time to death was 3 months (IQR 0–13). Men, unmarried patients, patients presenting with advanced HIV, not on TB treatment, and enrolled into the HIV program in later cohorts, had a shorter time to mortality and LTFU. Conclusion Our study demonstrated evidence of scale-up of HIV treatment programs in central Kenya. While most patients were enrolled at an advanced WHO clinical stage, overall 36-month mortality remained low, but occurred earlier during follow-up. Cohort LTFU at 36-months reduced in later years with the losses occurring within the 1st year of follow-up. Predictors of early mortality and LTFU included being male, single, separated or divorced, advanced WHO clinical stage, and among patients not on TB treatment. |
| first_indexed | 2024-04-12T15:21:14Z |
| format | Article |
| id | doaj.art-fb76bdd1cd0a419aa4856080a63b0eb7 |
| institution | Directory Open Access Journal |
| issn | 1471-2334 |
| language | English |
| last_indexed | 2024-04-12T15:21:14Z |
| publishDate | 2022-06-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Infectious Diseases |
| spelling | doaj.art-fb76bdd1cd0a419aa4856080a63b0eb72022-12-22T03:27:28ZengBMCBMC Infectious Diseases1471-23342022-06-0122111010.1186/s12879-022-07505-0Survival probability and factors associated with time to loss to follow-up and mortality among patients on antiretroviral treatment in central KenyaP. Wekesa0A. McLigeyo1K. Owuor2J. Mwangi3E. Ngugi4Centre for Health Solutions – KenyaCentre for Health Solutions – KenyaCentre for Health Solutions – KenyaDivision of Global HIV & TB, Centers for Disease Control and Prevention (CDC)Division of Global HIV & TB, Centers for Disease Control and Prevention (CDC)Abstract Background Retention of patients who are receiving antiretroviral therapy (ART) remains a challenge especially in the setting of rapid expansion of HIV services. Retention in care remains vital to the HIV care continuum, and has been associated with viral suppression and improved survival. This study aimed to ascertain survival rates, time to loss to follow-up (LTFU) or mortality events and factors associated with time to LTFU or mortality among patients enrolled on antiretroviral therapy at health facilities in central Kenya. Methods This was a retrospective cohort study among patients initiated on ART between 2004 and 2012 in central Kenya. Demographic characteristics, clinical characteristics and outcomes data were analyzed using Stata version 15.1. Competing risks regression analysis and cummulative incidence functions were used to estimate survival. Results A total of 31,346 patients were included, of whom 65.6% were female, 76.0% were aged between 20 and 50 years old, and 38.9% were diagnosed at WHO stage III. At 36 months, overall retention was 68.8%, LTFU was 27.1%, and mortality was 4.1%. The total person-years of follow up was 74,986. The incidence rate of LTFU was 9.99 per 100 person years for a total of 9383.25 person-years of follow up. The mortality rate was 1.25 per 100 person years for a total of 875.5 person-years among those who died. The median time to LTFU was 11 months (IQR 3–22) while median time to death was 3 months (IQR 0–13). Men, unmarried patients, patients presenting with advanced HIV, not on TB treatment, and enrolled into the HIV program in later cohorts, had a shorter time to mortality and LTFU. Conclusion Our study demonstrated evidence of scale-up of HIV treatment programs in central Kenya. While most patients were enrolled at an advanced WHO clinical stage, overall 36-month mortality remained low, but occurred earlier during follow-up. Cohort LTFU at 36-months reduced in later years with the losses occurring within the 1st year of follow-up. Predictors of early mortality and LTFU included being male, single, separated or divorced, advanced WHO clinical stage, and among patients not on TB treatment.https://doi.org/10.1186/s12879-022-07505-0Antiretroviral therapyHIVKenyaSurvivalLoss to follow-upMortality |
| spellingShingle | P. Wekesa A. McLigeyo K. Owuor J. Mwangi E. Ngugi Survival probability and factors associated with time to loss to follow-up and mortality among patients on antiretroviral treatment in central Kenya BMC Infectious Diseases Antiretroviral therapy HIV Kenya Survival Loss to follow-up Mortality |
| title | Survival probability and factors associated with time to loss to follow-up and mortality among patients on antiretroviral treatment in central Kenya |
| title_full | Survival probability and factors associated with time to loss to follow-up and mortality among patients on antiretroviral treatment in central Kenya |
| title_fullStr | Survival probability and factors associated with time to loss to follow-up and mortality among patients on antiretroviral treatment in central Kenya |
| title_full_unstemmed | Survival probability and factors associated with time to loss to follow-up and mortality among patients on antiretroviral treatment in central Kenya |
| title_short | Survival probability and factors associated with time to loss to follow-up and mortality among patients on antiretroviral treatment in central Kenya |
| title_sort | survival probability and factors associated with time to loss to follow up and mortality among patients on antiretroviral treatment in central kenya |
| topic | Antiretroviral therapy HIV Kenya Survival Loss to follow-up Mortality |
| url | https://doi.org/10.1186/s12879-022-07505-0 |
| work_keys_str_mv | AT pwekesa survivalprobabilityandfactorsassociatedwithtimetolosstofollowupandmortalityamongpatientsonantiretroviraltreatmentincentralkenya AT amcligeyo survivalprobabilityandfactorsassociatedwithtimetolosstofollowupandmortalityamongpatientsonantiretroviraltreatmentincentralkenya AT kowuor survivalprobabilityandfactorsassociatedwithtimetolosstofollowupandmortalityamongpatientsonantiretroviraltreatmentincentralkenya AT jmwangi survivalprobabilityandfactorsassociatedwithtimetolosstofollowupandmortalityamongpatientsonantiretroviraltreatmentincentralkenya AT engugi survivalprobabilityandfactorsassociatedwithtimetolosstofollowupandmortalityamongpatientsonantiretroviraltreatmentincentralkenya |